Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biohit Oyj Confirms FY 2012 Net Sales Guidance and Confirms FY 2013 / H1 2014 Earnings Guidance


Tuesday, 22 Jan 2013 04:00am EST 

Biohit Oyj announced that it still expects the net sales (revenue) of the Group in the fiscal year 2012 to fall somewhat short of the net sales achieved in the fiscal year 2011. The Company also expects to achieve a positive result during the fiscal year 2013 or in the first half of the fiscal year 2014. 

Company Quote

5.85
-0.03 -0.51%
8:09am EDT